棘细胞溶血性贫血患者死亡预测因素及肝移植结局
结果显示输血依赖和较低移植前血细胞比容等溶血严重程度指标独立预测90天死亡率升高,而肝移植后SCHA均快速完全缓解且结局良好。
要点
- 输血依赖者90天死亡风险显著升高(OR 9.14)。
- MELD-Na和Child-Turcotte-Pugh评分低估90天死亡率。
- 肝移植后SCHA均快速完全缓解,无复发。
核心结论
- SCHA患者实际死亡率高于MELD-Na或Child-Turcotte-Pugh评分预测,肝移植后SCHA均缓解且无复发。
- 多项溶血性贫血严重程度参数独立预测90天死亡率升高。
研究设计与样本
- 中位年龄53岁(四分位距42-59),女性占46.4%,11例(15.9%)接受肝移植。
主要发现
- 多变量模型中,校正年龄、性别、肝硬化病因、活动性/近期静脉曲张出血和Child-Turcotte-Pugh评分后,输血依赖的90天死亡OR为9.14(95%CI 2.46-34.00),移植前血细胞比容每降低6%的OR为4.73(95%CI 1.42-15.82)。
- 红细胞输血需求增加、血红蛋白降低、乳酸脱氢酶升高和间接胆红素升高也独立预测90天死亡率升高。
- MELD-Na和Child-Turcotte-Pugh评分一致显著低估90天死亡率,所有评分/分级的标准化死亡比(SMR)均>1:MELD-Na 20-29的SMR为2.42(1.18-4.44),Child-Turcotte-Pugh B级的SMR为4.46(1.64-9.90)。
临床怎么用
- 对SCHA患者应评估输血依赖性和溶血严重程度指标以识别90天死亡高风险者。
- 肝移植可快速完全缓解SCHA且无复发,移植后结局良好。
- MELD-Na和Child-Turcotte-Pugh评分可能低估SCHA患者死亡风险,需结合溶血指标综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Spur cell hemolytic anemia (SCHA) is a rare, acquired, nonimmune hemolytic anemia of decompensated cirrhosis. Data describing prognostic impact, outcomes of liver transplant, and clinical hematologic characteristics of SCHA are absent or limited. We performed a multicenter, 24-year observational cohort study of patients with SCHA, retrospectively analyzing hepatic and hematologic parameters, independent predictors of mortality, and long-term outcomes of liver transplant. Sixty-nine patients with SCHA met eligibility for inclusion. The median (interquartile range) age was 53 (42-59) years; 46.4% were female, and 11 (15.9%) received liver transplant. Thirty-nine patients (56.5%) were red blood celltransfusion-dependent. All 11 patients undergoing transplant had rapid and complete resolution of SCHA, with improvement in median hematocrit from 22.1% to 34.6% post-transplant (p = .001) and excellent post-transplant outcomes. In multivariable logistic models adjusting for age, sex, etiology of cirrhosis, active/recent variceal bleeding, and Child-Turcotte-Pugh score, transfusion dependence had an odds ratio (OR) for 90-day mortality of 9.14 (95% CI, 2.46-34.00) and reduced pre-transfusion hematocrit had an OR of 4.73 (95% CI, 1.42-15.82) per 6% decrease; increased red cell transfusion requirement, reduced hemoglobin, increased lactate dehydrogenase, and increased indirect bilirubin were also independently predictive of higher 90-day mortality. Model for end-stage liver disease (MELD)-Na and Child-Turcotte-Pugh scores consistently significantly underestimated 90-day mortality, with standardized mortality ratios (SMRs) >1 across all scores/classes [MELD-Na 20-29, SMR 2.42 (1.18-4.44); Child-Turcotte-Pugh class B, SMR 4.46 (1.64-9.90)]. In conclusion, SCHA is associated with substantial excess mortality than predicted by MELD-Na or Child-Turcotte-Pugh scores and uniformly resolves with liver transplant, without recurrence. Multiple parameters of hemolytic anemia severity independently predict higher 90-day mortality.
引用
- Virk ZM, Patel AA, Leaf RK, et al. Predictors of mortality and outcomes of liver transplant in spur cell hemolytic anemia. Am J Hematol. 2021. PMID: 34553418. doi:10.1002/ajh.26359
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。